Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Dina and Jafari, Am J Health Syst Pharm 57 (13) 1231-1241.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Angiotensin II-receptor antagonists: An overview


(July 1, 2000, Therapy Update). On page 1231, in the Abstract, the third-to-last sentence of paragraph 2 (beginning "Of the AT-II-receptor antagonists") should be disregarded. On page 1238, under Drug interactions, the same sentence (sentence 1 of paragraph 1) should again be disregarded. On page 1238, under Instructions for the patient, the final sentence refers to valsartan, not Iosartan. (Most of this correction notice appeared in the November 15, 2000, issue of AJHP.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.